white paper

The Pope, who was forced into a wheelchair was put on his feet with his therapy of Hungarian professor

Abstract

On the tenth anniversary of his election, Pope Francis recovered. Literally. He spent the last year in a wheelchair due to his severe knee problems, he was unable to walk because of his severe pain, he almost turned the thought of retiring in his head. But then he was cured by the therapy of a brilliant Hungarian medical professor. On-site report from the inventor’s son’s office.

31 December, XVI. For the first time since Benedict’s death, Pope Francis gave an interview. The 86-year-old Catholic pope told Sky News. The essence of the cheerful monologue was that the old man was healed, that the patient was a successful therapy for his knees, and he could get up from the wheelchair, where he was forced to do about a year ago.

Read More on index.hu

white paper

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

Abstract

GENEVA – (BUSINESS WIRE) – Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based innovations for ophthalmology, and its PBM device for the treatment of early and intermediate dry AMD.1 LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living with early to intermediate dry AMD.2,* Dry AMD is a progressive disease typically treated in late stage, with limited treatment options.2

 

Read More on businesswire.com or download the PDF.

white paper

Harnessing Medical Innovation to Make America Healthy Again

Abstract

Join The Heritage Foundation and leading medical scientists for a discussion of cutting edge medical technology and its wider implementation to make Americans healthier. Photobiomodulation (PBM) and hyperbaric oxygen therapy (HBOT) are two proven treatments that stimulate cell growth in patients suffering from a vast array of conditions. Managing pain, promoting wound healing, and treating brain injuries are just a few of the applications for these treatments.

 

Read More on heritage.org or download the PDF.

white paper

Photobiomodulation Clinic at Mass General Offers a Promising New Treatment for Neuropsychiatric Disorders

Abstract

Transcranial photobiomodulation (PBM) is emerging as an innovative approach to treat various neuropsychiatric conditions, including major depressive disorder, generalized anxiety disorder, traumatic brain injury, and Alzheimer’s disease and other types of dementia. The Brain Photobiomodulation Clinic at Mass General Hospital, under the direction of Paolo Cassano, MD, PhD, offers this cutting-edge treatment for patients with treatment-resistant neuropsychiatric disorders.

 

Read More on mghpsychnews.org or download the PDF.

white paper

Lighting the Way to a Healthier America

Abstract

The Make America Healthy Again (MAHA) movement is now national policy with Trump establishing the MAHA Commission and Robert F. Kennedy, Jr. as the Secretary of the Department of Health & Human Services (HHS).

Americans are universally concerned about their health, but well-financed and entrenched interests are thwarting MAHA. Big Pharma spends $400 million a year on lobbying and contributes $90 million each election cycle. Big food spends $130 million a year on lobbying and contributes $42.5 million each election cycle.

 

Read More on citizenoversight.blogspot.com or download the PDF.

white paper

Local athletes to be subjects of new, international study

Abstract

SHEPHERDSTOWN — Athletes from Shepherd University will soon be some of the subjects of a new study being conducted by photobiomodulation (PBM) therapy researchers.

According to Ann Liebert, who is the coordinator of photomolecular research at Sydney Adventist Hospital in Australia, the research will focus on whether or not PBM therapy heals concussions.

 

Read More on journal-news.net or download the PDF.

white paper

Military Explores Light Therapy for Brain Injuries

Abstract

The U.S. Department of Defense (DOD) is taking steps to explore how noninvasive, nondrug light therapy can help military members and veterans recover from traumatic brain injuries (TBI).

 

Read More on heartlanddailynews.com or download the PDF

white paper

Poulsbo firm gets FDA OK to treat common eye problem

Abstract

Clark Tedford has been smiling so much he said his jaw is starting to hurt.

He has good reason to be happy – his company, Lumithera in Poulsbo, a family-owned medical device company, recently received word that the Food and Drug Administration has approved their new product, Valeda, a non-invasive treatment for degenerative eye disease.

“The target we’re going after, age-related macular degeneration, is the largest cause of vision loss in adults over the age of 65,” said Tedford, who has a doctorate in pharmacology. “There aren’t a lot of alternatives for these patients, and over years they’ll lose their vision slowly, and it can be devastating.”

Read More on kitsapdailynews.com or download the PDF.

white paper

LumiThera Receives FDA Authorization for Valeda Treatment for Dry AMD

Abstract

The U.S. FDA has granted LumiThera authorization to market its Valeda Light Delivery System, the first FDA-authorized device designed to treat vision loss in patients with dry age-related macular degeneration (AMD). This significant approval, obtained through the De Novo authorization pathway, marks a major milestone in noninvasive treatments for dry AMD.

 

Read More on ophthalmologybreakingnews.com or download the PDF.

white paper

Red Light Therapy: Benefits For Athletic Performance, Recovery, And Pain Relief

Abstract

You’ve seen the celebrities and influencers donning futuristic LED face masks to improve signs of aging and acne. The technology behind it—red light therapy(RLT), which is a form of photobiomodulation, as scientists say—has potential perks that are more than skin-deep.

Elite athletes, for example, hop into specialized red light beds to speed up recovery time. Doctors use it as an adjunct treatment for patients with chronic and acute pain and are hopeful it may help curb the amount of opioids they prescribe post-op.

Read More on womenshealthmag.com or Download the PDF